[1] |
Andersen AN,Gianaroli L,Felberbaum R,et al.Assisted reproductive technology in Europe,2001.Resultsgenerated from European registers by ESHRE[J].Hum Reprod,2005,20(5):1158-1176.
|
[2] |
Wang JG,Douglas NC,Dicken C,et al.Cryopreservation os supernumerary high quality embryos predicts favorable outcomes for patients undergoing repeated cycles of in vitro fertilization[J].Fertil Steril,2008,89(2):368-374.
|
[3] |
罗燕群,刘风华,易艳红,等.年龄、移植胚胎数目、质量与临床妊娠率的关系[J].生殖医学杂志,2014,23(5):361-366.
|
[4] |
李秋华,全松,陈雷宁,等.160例重复体外受精-胚胎移植周期临床结局分析[J].南方医科大学学报,2010,30(2):236-238.
|
[5] |
魏晗,李尚为,曾珣,等.三种控制性超排卵方案在高龄妇女体外受精-胚胎移植中的疗效分析[J]华西医学,2012,27(12):1855-1858.
|
[6] |
张力佳,罗琛,罗轶群,等.反复植入失败的实验室策略[J].妇产与遗传(电子版),2013,3(3):55-58.
|
[7] |
徐艳文.胚胎发育潜能的评估及其研究进展[J].生殖医学杂志,2011,20(6):435-437.
|
[8] |
方丛,黄睿,李婷婷,等.两次移植提高反复体外受精-胚胎移植失败患者的妊娠率的研究[J].生殖医学杂志,2012,21(2):122-124.
|
[9] |
韩丹,章志国,郝燕,等.再次体外受精-胚胎移植获卵数的改变及其影响因素的分析[J].安徽医科大学学报,2015,50(12):1781-1785.
|
[10] |
焦雪丹,李予,王文军,等.体外受精-胚胎移植重复周期助孕结局的回顾性分析[J].国际妇产科杂志,2011,38(5):461-464.
|
[11] |
Moragianni VA,Penzias AS.Cumulative live-birth rates after assisted reproductive technology[J].Curr Opin Obstet Gynecol,2010,22(3):189-192.
|
[12] |
Stoop D,Ermini B,Polyzos NP,et al.Reproductive potential of ametaphaseⅡoocyte retrieved after ovarian stimulation:an analysis of 23354 ICSI cycle[J].Hum Reprod,2012,27(7):2030-2035.
|
[13] |
Sunkara SK,Rittenberg V,Rainev-Fenning N,et al.Association between the number of eggs and live birth in IVF treatment:an analysis of 400 135 treatment cycles[J].Hum Reprod,2011,26(7):1768-1774.
|
[16] |
周蓉,黄楠,谢守珍.体外受精-胚胎移植中影响胚胎种植成功的因素回归分析[J].中国性科学,2015,24(6):101-103.
|
[17] |
韩丹,章志国,郝燕,等.再次体外受精-胚胎移植获卵数的改变及其影响因素的分析[J].安徽医科大学学报,2015,50(12):1781-1784.
|
[18] |
丁佳佳,赵恩锋,田爽,等.不同剂量的GnRH-a在诱导排卵中的临床效果观察[J].中国性科学,2015,24(3):81-83.
|
[19] |
吴香春.多囊卵巢综合症患者不同促排卵方案临床疗效分析[J].中国性科学,2014,23(5):35-37.
|
[14] |
Eppsteiner EE,Sparks AE,Liu D,et al.Change in oocyte yield in repeated in vitro fertilization cycles:effect of ovarian reserve[J].Fertil Steril,2014,101(2):399-402.
|
[15] |
Sterrenberg MD,Veltman-Verhulst SM,Eijkemans MJ,et al.Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulationin in vitro fertilization in presumed normal responders younger than 39 years:a meta-analysis[J].Hum Reprod Update,2011,17(2):184-196.
|